Registration for a live webinar on 'Gamma-delta T cells for immunotherapy of cancer' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- General Virology
-
1. Principles of virology
- Prof. Vincent Racaniello
-
2. Antiviral drugs (non-HIV)
- Prof. Megan Shaw
-
3. The type I interferon system and viruses
- Dr. Adolfo Garcia-Sastre
-
4. Immune responses to viruses
- Prof. Paul Klenerman
- Emerging Pathogens
-
5. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
- Dr. Marietjie Venter
- Mrs. Orienka Hellferscee
-
6. Emerging respiratory viruses - discoveries between 2001 and 2005
- Prof. Ron Fouchier
-
7. Usage of vaccines and therapeutics in public health emergencies 1
- Prof. Gary Kobinger
-
8. Usage of vaccines and therapeutics in public health emergencies 2
- Prof. Gary Kobinger
-
9. Influenza virus pandemics: past and future
- Prof. Peter Palese
-
10. SARS-CoV and other emerging coronaviruses
- Prof. Ralph Baric
-
11. Dengue, Zika and Chickungunya viruses
- Prof. Ana Fernandez-Sesma
-
12. Biodefense challenges
- Dr. David Franz
- Important Pathogens and their Diseases
-
13. Natural history and pathogenesis of herpes virus infections
- Prof. Richard Whitley
-
14. Cytomegalovirus biology
- Prof. Domenico Tortorella
-
15. Hepatitis C virus: discovery, cure and protection
- Dr. Matthew Evans
-
16. Fundamentals of HIV biology
- Prof. Viviana Simon
-
17. Measles
- Prof. Diane E. Griffin
- New Frontiers
-
20. Viruses as anticancer weapons
- Prof. Roberto Cattaneo
-
21. Novel approaches to diagnosis of viral infections
- Prof. W. Ian Lipkin
- Archived Lectures *These may not cover the latest advances in the field
-
22. Principles of virology I
- Prof. Richard Condit
-
23. Principles of virology II
- Prof. Richard Condit
-
24. Complex DNA viruses: herpes virus
- Dr. John Blaho
-
25. Adeno-associated viruses (AAV)
- Prof. Kenneth Berns
-
26. Poxviruses: smallpox (variola), vaccinia and monkeypox
- Prof. Paula Traktman
-
27. Can HPV testing be the sole primary cervical screening modality?
- Prof. Jack Cuzick
-
28. From viruses to oncolytics
- Prof. Roberto Cattaneo
-
29. Non HIV antivirals
- Prof. Mary Klotman
-
30. Gastroenteritis viruses
- Prof. Mary Estes
-
31. Biodefense challenges
- Dr. Connie Schmaljohn
-
33. The past, present and future of vaccination
- Prof. Stanley Plotkin
-
34. Filoviruses
- Dr. Christopher Basler
-
35. Bunyaviruses
- Prof. Richard Elliott
-
36. The immunobiology of HIV
- Prof. Norman Letvin
-
37. Hepatitis C and HCV
- Prof. Stanley Lemon
Printable Handouts
Navigable Slide Index
- Introduction
- The spectrum of hepatitis viruses
- Pathologic events in chronic hepatitis C
- Global distribution of HCV infection
- Emergence of HCV-related liver cancer
- Liver cancer rates in the U.S. by race and sex
- Hepatitis C pathogenesis: cellular level
- Hepatitis C pathogenesis: system level
- Hepatitis C pathogenesis: host consequences
- HCV model systems
- Hepatitis C virus
- Cis-acting RNA elements of HCV
- HCV 5' RNA structure
- Translation of HCV genome vs. cellular mRNA
- HCV IRES - 40S subunit binding affinity
- IRES binding alters 40S conformation
- Role of 3' terminal stem-loops of HCV RNA
- HCV proteins hypothetical membrane topology
- Hepatitis C virus structural proteins
- Core protein
- "F" protein
- HCV envelope proteins
- p7 protein: a target for drug discovery?
- NS2 protein
- NS2/3 proteinase
- NS3 protein
- NS3/4A proteinase
- NS3/4A processing of nonstructural proteins
- NS3 helicase/NTPase
- Bifunctional NS3/4A proteinase/helicase
- NS4A protein
- NS4B protein
- NS5A protein
- NS5B RNA-dependent RNA polymerase
- Hepatitis C virus life cycle
- Polyprotein functions in the viral lifecycle
- Subgenomic HCV replicon polyprotein
- Dicistronic subgenomic HCV replicons
- Subgenomic HCV replicon life cycle
- HCV-infected Huh-7.5 hepatoma cells
- Host factors - pathogenesis and viral replication
- Cytoplasmic colocalization of Rb and NS5A
- Viral persistence - central issue in hepatitis C
- Possible mechanisms of HCV persistence
- Virus-activated pathways lead to IFN synthesis
- Suppression of HCV viremia with BILN 2061
- Summary and conclusions
Topics Covered
- The spectrum of hepatitis viruses
- Global distribution of HCV infection
- Associated diseases
- Hepatitis C pathogenesis
- HCV model systems
- Replication of HCV RNA
- Hypothetical membrane topology of HCV proteins
- HCV structural proteins
- p7 protein
- Hepatitis C virus life cycle
- Polyprotein functions in the viral life cycle
- Subgenomic HCV replicon life cycle
- The central issue in hepatitis C is viral persistence
- Possible mechanisms of HCV persistence
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Lemon, S. (2007, October 1). Hepatitis C and HCV [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 29, 2023, from https://hstalks.com/bs/365/.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Stanley Lemon has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.